Zenth Health Sciences is the healthcare and pharmaceutical arm of Aevum Zenth Conglomerate. Spanning pharmaceutical R&D, gene therapy, medical devices, telemedicine networks, and precision medicine, we operate across 45 countries — transforming how the world diagnoses, treats, and prevents disease.
Every initiative within Zenth Health Sciences falls under one of these six strategic pillars, each driving breakthroughs in human health.
Designing and developing novel therapeutics across oncology, neurology, immunology, and rare diseases. Our pipeline includes 120+ compounds spanning pre-clinical to Phase III trials.
Learn more →Pioneering CRISPR-based treatments, gene editing platforms, and personalized genomic medicine. Our labs have delivered 30+ FDA-approved gene therapies to date.
Learn more →Engineering next-generation surgical robotics, implantable devices, diagnostic imaging systems, and wearable health monitors for clinical and home use.
Learn more →Operating one of the world's largest digital health platforms, connecting 2.4M patients with specialists across 45 countries through AI-assisted diagnostics.
Learn more →Matching treatments to individual genetic profiles using our proprietary AI-driven analytics engine, ZenthBio AI — reducing adverse drug reactions by 73%.
Learn more →Running 200+ concurrent clinical trials globally with our proprietary decentralized trial framework, cutting recruitment time by 60% and costs by 45%.
Learn more →Our research divisions target the most consequential challenges in human health and longevity.
Our ZenthBio AI platform processes 10^18 molecular interactions daily, identifying novel drug candidates in weeks rather than years. We've accelerated our oncology pipeline by 4x compared to industry averages.
Targeting Alzheimer's, Parkinson's, and ALS with our proprietary blood-brain barrier crossing nanotechnology platform. Three Phase III trials underway for novel tau-protein therapies.
Pioneering induced pluripotent stem cell (iPSC) therapies for organ regeneration, tissue repair, and treating degenerative conditions with patient-derived cells.
Developing next-generation CAR-T cell therapies for solid tumors, autoimmune diseases, and infectious conditions. Our universal CAR-T platform reduces treatment timelines from months to days.
Landmark achievements that are reshaping medicine and improving lives worldwide.
Our CRISPR-based gene editing therapy received FDA approval for sickle cell disease, offering a functional cure with a single infusion. Over 12,000 patients treated in the first quarter.
Gene TherapyOur proprietary AI platform identified a novel oncology compound in 11 days — a process that traditionally takes 3-5 years. The compound entered Phase I trials within 6 months.
AI / Drug DiscoveryFirst fully bioengineered heart valve derived from patient stem cells completed Phase III trials with 98.7% structural durability at 2-year follow-up. Zero rejection events reported.
Regenerative MedicineMRNA-based universal influenza vaccine showed 96% efficacy across all known flu strains in Phase III trials. Manufacturing capacity scaled to 2 billion doses annually.
Vaccine DevelopmentOur minimally invasive neural implant detects Alzheimer's biomarkers 7-10 years before symptom onset with 99.2% accuracy. Currently in multi-center Phase II trials.
NeurotechnologyFirst CAR-T therapy effective across 14 different solid tumor types. Response rates exceeded 80% in melanoma, lung, and pancreatic cancer cohorts.
ImmunotherapyStrategically located facilities enabling 24/7 global healthcare operations.
Our decentralized clinical trial framework operates across 85 sites in 32 countries, leveraging digital health tools, AI-driven patient matching, and real-world evidence collection to accelerate drug development.
Whether you're a molecular biologist, AI engineer, clinical researcher, or manufacturing specialist — Zenth Health Sciences offers the resources, infrastructure, and mission-driven culture to make world-changing discoveries.
State-of-the-art research facilities across 8 global hubs
Top-tier salaries, equity, and patent bonuses
Transfer between any of our 8 international hubs
Unlimited conference and publication support
Whether you're a research institution, pharmaceutical partner, healthcare provider, or potential investor — let's explore how we can advance healthcare together.